Fundamentun, LLC Danaher Corp Transaction History

Fundamentun, LLC

$1.34 Billion
Q3 2024

A detailed history of Fundamentun, LLC transactions in Danaher Corp stock. As of the latest transaction made, Fundamentun, LLC holds 1,352 shares of DHR stock, worth $312,447. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,352

Previous 1,281 5.54%

Holding current value

$312,447

Previous $320,000 17.19%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$239.25 - $280.76 $16,986 - $19,933	71 Added 5.54%	1,352 $375,000
Q2 2024 Jul 24, 2024	BUY	$235.51 - $267.98 $12,717 - $14,470	54 Added 4.4%	1,281 $320,000
Q1 2024 Apr 16, 2024	BUY	$224.58 - $256.19 $23,580 - $26,899	105 Added 9.36%	1,227 $306,000
Q4 2023 Jan 24, 2024	BUY	$185.1 - $233.13 $45,719 - $57,583	247 Added 28.23%	1,122 $259,000
Q2 2023 Jul 18, 2023	BUY	$224.99 - $256.14 $7,649 - $8,708	34 Added 4.04%	875 $210,000
Q1 2023 May 01, 2023	SELL	$239.75 - $277.0 $2,397 - $2,770	-10 Reduced 1.18%	841 $211,000
Q4 2022 Jan 19, 2023	BUY	$241.42 - $282.29 $241 - $282	1 Added 0.12%	851 $0
Q3 2022 Oct 24, 2022	SELL	$247.06 - $1507.4 $21,741 - $132,651	-88 Reduced 9.38%	850 $220,000
Q2 2022 Sep 06, 2022	SELL	$237.11 - $299.66 $28,927 - $36,558	-122 Reduced 11.51%	938 $238,000
Q1 2022 Apr 26, 2022	SELL	$257.27 - $315.76 $34,731 - $42,627	-135 Reduced 11.3%	1,060 $311,000
Q4 2021 Jan 14, 2022	SELL	$292.08 - $329.01 $250,896 - $282,619	-859 Reduced 41.82%	1,195 $393,000
Q3 2021 Oct 19, 2021	BUY	$272.21 - $332.43 $559,119 - $682,811	2,054 New	2,054 $625,000

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.

Account